"The Central Licensing Authority has granted permission to Bharat Biotech International Ltd to manufacture for sale of the pharmaceutical formulation,".
Earlier on Sunday, Drug Controller General of India (DCGI) V.G. Somani announced that Bharat Biotech's 'Covaxin' has been approved for "restricted use in emergency situation". The approval has also been given to Serum Institute of India's 'Covishield' vaccine.
The Subject Expert Committee of Central Drugs Standards Control Organisation had recommended restricted use of Covaxin "in emergency situation in public interest as an abundant precaution, in clinical trial mode, specially in the context of infection by mutant strains". Officals say that it will be used as backup in case of spike in cases.
Covaxin has to be administered in two doses and can be stored at 2-8 degree Celsius. This is a major relief for India which has the second highest number of infections in the world after the US.
Bharat Biotech is India's first indigenous vaccine for coronavirus. The inactivated virus vaccine is developed in collaboration with the Indian Council of Medical Research (ICMR) and the National Institute of Virology (NIV).
"Covaxin has generated excellent safety data with robust immune responses to multiple viral proteins that persist," Krishna Ella, Chairman and Managing Director of the pharmaceutical firm said following the approval. (IANS)
Are you an Ayurveda doctor? Download our App from Google PlayStore now!
Download NirogStreet App for Ayurveda Doctors. Discuss cases with other doctors, share insights and experiences, read research papers and case studies. Get Free Consultation 9625991603 | 9625991607 | 8595299366
New Delhi, Jan 25 (IANS) In a sigh of relief, the first frontline healthcare worker in the national capital to suffer due to the coronavirus pandemic in March beamed with joy ...
Hyderabad, Jan 25 (IANS) A 13-year-old boy from Telangana, who developed a smart wristband to monitor Alzheimer's patients, is one of the recipients of Pradhan Mantri Rashtriy...
London, Jan 25 (IANS) Even before the first cases of Covid-19 in Europe were announced at the end of January 2020, signals that something strange was happening were already ci...